211 related articles for article (PubMed ID: 11965333)
1. Free choice of sickness funds in regulated competition: evidence from Germany and The Netherlands.
Gress S; Groenewegen P; Kerssens J; Braun B; Wasem J
Health Policy; 2002 Jun; 60(3):235-54. PubMed ID: 11965333
[TBL] [Abstract][Full Text] [Related]
2. Risk adjustment and risk selection on the sickness fund insurance market in five European countries.
van de Ven WP; Beck K; Buchner F; Chernichovsky D; Gardiol L; Holly A; Lamers LM; Schokkaert E; Shmueli A; Spycher S; Van de Voorde C; van Vliet RC; Wasem J; Zmora I
Health Policy; 2003 Jul; 65(1):75-98. PubMed ID: 12818747
[TBL] [Abstract][Full Text] [Related]
3. [Switching sickness funds and risk compensation mechanisms in the statutory health insurance system in Germany--empirical results from the cooperative health research in the region of Augsburg (KORA)].
Werner A; Reitmeir P; John J
Gesundheitswesen; 2005 Aug; 67 Suppl 1():S158-66. PubMed ID: 16032535
[TBL] [Abstract][Full Text] [Related]
4. Risk adjusted premium subsidies and risk sharing: key elements of the competitive sickness fund market in the Netherlands.
Lamers LM; van Vliet RC; van de Ven WP
Health Policy; 2003 Jul; 65(1):49-62. PubMed ID: 12818745
[TBL] [Abstract][Full Text] [Related]
5. Consumer price sensitivity in Dutch health insurance.
van Dijk M; Pomp M; Douven R; Laske-Aldershof T; Schut E; de Boer W; de Boo A
Int J Health Care Finance Econ; 2008 Dec; 8(4):225-44. PubMed ID: 18709549
[TBL] [Abstract][Full Text] [Related]
6. [Market Concentration in the Statutory Health Insurance of Germany since the Introduction of Free Choice of Sickness Funds].
Götze R
Gesundheitswesen; 2016 Nov; 78(11):715-720. PubMed ID: 25760099
[No Abstract] [Full Text] [Related]
7. [Effect of competition-oriented reform in the Netherlands health care system on the relationship between primary care physicians, insurance groups and insured patients].
Groenewegen PP; Gress S
Gesundheitswesen; 2000 Nov; 62(11):568-76. PubMed ID: 11151698
[TBL] [Abstract][Full Text] [Related]
8. Managed competition and consumer price sensitivity in social health insurance.
Schut FT; Hassink WH
J Health Econ; 2002 Nov; 21(6):1009-29. PubMed ID: 12475123
[TBL] [Abstract][Full Text] [Related]
9. Consumer price sensitivity and social health insurer choice in Germany and The Netherlands.
Schut FT; Gress S; Wasem J
Int J Health Care Finance Econ; 2003 Jun; 3(2):117-38. PubMed ID: 14626009
[TBL] [Abstract][Full Text] [Related]
10. Risk adjustment and risk selection in Europe: 6 years later.
van de Ven WP; Beck K; Van de Voorde C; Wasem J; Zmora I
Health Policy; 2007 Oct; 83(2-3):162-79. PubMed ID: 17270311
[TBL] [Abstract][Full Text] [Related]
11. Needs for further improvement: risk adjustment in the German health insurance system.
Buchner F; Wasem J
Health Policy; 2003 Jul; 65(1):21-35. PubMed ID: 12818743
[TBL] [Abstract][Full Text] [Related]
12. Sustaining Medicare through consumer choice of health funds: lessons from the Netherlands.
Stoelwinder JU; Paolucci F
Med J Aust; 2009 Jul; 191(1):30-2. PubMed ID: 19580534
[TBL] [Abstract][Full Text] [Related]
13. Managed competition in The Netherlands: lessons from five years of health care reform.
van de Ven W; Rutten F
Aust Health Rev; 1995; 18(1):9-27. PubMed ID: 10141966
[TBL] [Abstract][Full Text] [Related]
14. Health-adjusted premium subsidies in the Netherlands.
van de Ven WP; van Vliet RC; Lamers LM
Health Aff (Millwood); 2004; 23(3):45-55. PubMed ID: 15160802
[TBL] [Abstract][Full Text] [Related]
15. Consumer mobility in social health insurance markets : a five-country comparison.
Laske-Aldershof T; Schut E; Beck K; Gress S; Shmueli A; Van de Voorde C
Appl Health Econ Health Policy; 2004; 3(4):229-41. PubMed ID: 15901197
[TBL] [Abstract][Full Text] [Related]
16. Belgium: risk adjustment and financial responsibility in a centralised system.
Schokkaert E; Van de Voorde C
Health Policy; 2003 Jul; 65(1):5-19. PubMed ID: 12818742
[TBL] [Abstract][Full Text] [Related]
17. Introducing risk adjustment and free health plan choice in employer-based health insurance: Evidence from Germany.
Pilny A; Wübker A; Ziebarth NR
J Health Econ; 2017 Dec; 56():330-351. PubMed ID: 29248059
[TBL] [Abstract][Full Text] [Related]
18. Risk selection in the German public health insurance system.
Nuscheler R; Knaus T
Health Econ; 2005 Dec; 14(12):1253-71. PubMed ID: 15942977
[TBL] [Abstract][Full Text] [Related]
19. The marginal success of regulated competition policy in the Netherlands.
Lieverdink H
Soc Sci Med; 2001 Apr; 52(8):1183-94. PubMed ID: 11281402
[TBL] [Abstract][Full Text] [Related]
20. Measuring customer preferences in the German statutory health insurance.
Pendzialek JB; Simic D; Stock S
Eur J Health Econ; 2017 Sep; 18(7):831-845. PubMed ID: 27655398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
